Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Biodegradable polymers: Chymotrypsin degradation of a low molecular weight poly(ester‐urea) containing phenylalanine1979 · 87 citations
2. 2<i>In vivo</i> behavior of poly(1,3‐trimethylene carbonate) and copolymers of 1,3‐trimethylene carbonate with <scp>D</scp>,<scp>L</scp>‐lactide or ϵ‐caprolactone: Degradation and tissue response2003 · 257 citations
3. 3NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real‐Time in vivo Monitoring of Drug Release2015 · 58 citations
4. 4Biomedical Applications of Chemically and Microbiologically Synthesized Poly(Glutamic Acid) and Poly(Lysine)2004 · 140 citations
5. 5Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers2008 · 1,262 citations